Enhanced regional AT2-receptor and PKCε expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue 2, 2001, Pages 134-140

  Jugdutt, Bodh I ^a,b   Balghith, Mohammed ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

AT1 receptor; AT2 receptor; cGMP; Ischaemia reperfusion; PKC

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; CARDIOTONIC AGENT; CYCLIC GMP; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C EPSILON;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; DOG; DRUG ANTAGONISM; ENZYMOLOGY; HEART INFARCTION; HEART MUSCLE; HEART RATE; METABOLISM; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CYCLIC GMP; DOGS; HEART RATE; ISOENZYMES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 0035533452     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2001.015     Document Type: Article

References (29)

1. Yoshiyama M, Kim S, Yamagishi H et al. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J 1994;128:1-6.
2. Werrmann JG, Cohen SM. Use of losartan to examine the role of the cardiac renin-angiotensin system in myocardial dysfunction during ischemia and reperfusion. J Cardiovasc Pharmacol 1996;27:177-82.
3. Yang BC, Phillips MI, Ambuehl PEJ, Shen LP, Mehta P, Mehta JL. Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat heart. Circulation 1997;96:922-6.
4. 2 receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 1998;32:1787-96.
5. ε proteins and cGMP. J Cardiovasc Pharmacol Thera 2000;5:301-11.
6. 2 receptor expression, and IP3 receptor and PKCE proteins. JRAAS 2000;1:184-95.
7. Ford WR, Khan MI, Jugdutt BI. Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog. Can J Cardiol 1998;14:73-80.
8. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997;99:1926-35.
9. 2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens 1993;11:S234-S235.
10. Jugdutt, BI, Xu Y, Balghith M, Menon V. Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: Role of angiotensin II type 2 receptor. JRAAS 2001;2:S162-S166.
11. Ping P, Takano H, Zhang J et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits. A signaling mechanism for both nitric-oxide-induced and ischemia-induced preconditioning. Circ Res 1999;84:587-604.
12. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 1997;33:422-32.
13. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE. Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate. Circulation 1995;92:926-34.
14. Jugdutt BI. Effect of reperfusion on ventricular mass, topography and function during healing of anterior infarction. Am J Physiol 1997;272:H1205-11.
15. Douglas PS, Tallant B. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension. J Am Coll Cardiol 1991;17:530-6.
16. Becker LC, Jeremy RW, Schaper J, Schaper W. Ultrastructural assessment of myocardial necrosis occurring during ischemia and 3-h reperfusion in the dog. Am J Physiol 1999;277:H243-H252.
17. Jugdutt BI, Becker LC, Hutchins GM. Early changes in collateral blood flow during myocardial infarction in conscious dogs. Am J Physiol 1979;237:H371-H380.
18. 1 receptor antagonist candesartan. Basic Res Cardiol 1999;94:208-14.
19. 2) angiotensin receptor. Proc Natl Acad Sci USA 1999;96:6506-10.
20. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998;31:349-55.
21. Seyedi N, Xu XB, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995;26:164-70.
22. Jugdutt BI. Angiotensin II receptor blockers. In Crawford MH (ed): Cardiology Clinics Annual of Drug Therapy (vol 2). Saunders, Philadelphia, PA, pp. 1-17, 1998.
23. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-60.
24. 2 knockout mice. Biochem Biophys Res Comm 1999;258:194-8.
25. 1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998;101:527-35.
26. Youhua Z, Shouchun X. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system. Chin Med J 1995;108:28-32.
27. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998;31:342-8.
28. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrisin DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95:588-93.
29. Brew EC, Mitchell MB, Rehring TF et al. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 1995;269:H1370-H1378.